Syndicated from In Sequence RSS Feed
SOLiD customers said they are not concerned that the deal will affect their ability to obtain service and support, and believe Invitrogens biochemistry expertise could help the platform. But they also caution that any disruption from the acquisition could cause the SOLiD to fall behind the competition.
More...
SOLiD customers said they are not concerned that the deal will affect their ability to obtain service and support, and believe Invitrogens biochemistry expertise could help the platform. But they also caution that any disruption from the acquisition could cause the SOLiD to fall behind the competition.
More...